Viridian Therapeutics Inc (FRA:1S1)
€ 13.5 -0.2 (-1.46%) Market Cap: 864.99 Mil Enterprise Value: 549.50 Mil PE Ratio: 0 PB Ratio: 2.92 GF Score: 58/100

Viridian Therapeutics Inc (FRA:1S1) Transcripts

  • 1